S&P 500 Healthcare Weighting At Multi-Decade Lows
S＆P 500医疗保健加权在多十年的低谷收入季节已经结束了大型生物制药的股票，随着医疗保健行业在标准普尔500中的权重跌至多年级低点，许多名称的巨大抛售。在特朗普政府最受欢迎的国家（MFN）医疗补助的定价建议和药品关税的前景中，这一领域的悲观主义提升。 Here are some of the highlights of the note titled "Global Healthcare: Pharmaceuticals: Friday Fodder: Slimmer Positioning Into The August Lull": Earnings season ended with
